Search research articles
Contact Us
Filters
Showing results (101-110 of 165) with videos related to
Page
of 17
Sort By:
Palliative Medicine Reports
|
April 1, 2024
Understanding the Utility of Less Than Six-Month Prognosis Using Administrative Data Among U.S. Nursing Home Residents With Cancer
Long Vu, Siran M Koroukian, Sara L Douglas, et al.
Urologic Oncology
|
April 16, 2017
Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer
Kai H Hammerich, Timothy F Donahue, Inger L Rosner, et al.
Current Oncology Reports
|
July 13, 2024
Reducing racial and ethnic disparities in cardiovascular outcomes among cancer survivors
Min Choon Tan, Nickolas Stabellini, Jia Yi Tan, et al.
Cancer
|
July 6, 2017
Longitudinal regret after treatment for low- and intermediate-risk prostate cancer
Lauren M Hurwitz, Jennifer Cullen, Daniel J Kim, et al.
Pathology
|
September 24, 2020
Prognostic features of Annexin A2 expression in prostate cancer
Shyh-Han Tan, Denise Young, Yongmei Chen, et al.
The Oncologist
|
April 29, 2023
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes
Sudipto Mukherjee, Weichuan Dong, Nicholas K Schiltz, et al.
Urologic Oncology
|
January 24, 2017
A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy
John S Banerji, Lauren M Hurwitz, Jennifer Cullen, et al.
Current Treatment Options in Oncology
|
April 18, 2021
Cardiovascular Toxicities of Androgen Deprivation Therapy
Azariyas A Challa, Adam Christopher Calaway, Jennifer Cullen, et al.
Frontiers in Oncology
|
February 12, 2021
Age and Tumor Differentiation-Associated Gene Expression Based Analysis of Non-Familial Prostate Cancers
Shashwat Sharad, Travis C Allemang, Hua Li, et al.
European Urology
|
August 18, 2019
Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities
Grace Lu-Yao, Nikita Nikita, Scott W Keith, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 165) with videos related to
Sort By:
Page
of 17
Palliative Medicine Reports
|
April 1, 2024
Understanding the Utility of Less Than Six-Month Prognosis Using Administrative Data Among U.S. Nursing Home Residents With Cancer
Long Vu, Siran M Koroukian, Sara L Douglas, et al.
Urologic Oncology
|
April 16, 2017
Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer
Kai H Hammerich, Timothy F Donahue, Inger L Rosner, et al.
Current Oncology Reports
|
July 13, 2024
Reducing racial and ethnic disparities in cardiovascular outcomes among cancer survivors
Min Choon Tan, Nickolas Stabellini, Jia Yi Tan, et al.
Cancer
|
July 6, 2017
Longitudinal regret after treatment for low- and intermediate-risk prostate cancer
Lauren M Hurwitz, Jennifer Cullen, Daniel J Kim, et al.
Pathology
|
September 24, 2020
Prognostic features of Annexin A2 expression in prostate cancer
Shyh-Han Tan, Denise Young, Yongmei Chen, et al.
The Oncologist
|
April 29, 2023
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes
Sudipto Mukherjee, Weichuan Dong, Nicholas K Schiltz, et al.
Urologic Oncology
|
January 24, 2017
A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy
John S Banerji, Lauren M Hurwitz, Jennifer Cullen, et al.
Current Treatment Options in Oncology
|
April 18, 2021
Cardiovascular Toxicities of Androgen Deprivation Therapy
Azariyas A Challa, Adam Christopher Calaway, Jennifer Cullen, et al.
Frontiers in Oncology
|
February 12, 2021
Age and Tumor Differentiation-Associated Gene Expression Based Analysis of Non-Familial Prostate Cancers
Shashwat Sharad, Travis C Allemang, Hua Li, et al.
European Urology
|
August 18, 2019
Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities
Grace Lu-Yao, Nikita Nikita, Scott W Keith, et al.
Page
of 17